多发性硬化症的失能症:免疫球蛋白Y补充剂可以帮助吗?
Andreea Cristina Paraschiv1, Vitalie Vacaras2, Cristina Nistor3
1Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.. . cristina.andreea.paraschiv@gmail.com.
Journal of gastrointestinal and liver diseases : JGLD
|March 30, 2024
概括
肠道微生物不平衡与多发性硬化症 (MS) 有关. 免疫球蛋白Y (IgY) 补充剂在调节肠道细菌和免疫反应方面表现有前途,可能为MS管理提供新的治疗途径.
科学领域:
- 神经免疫学 神经免疫学
- 微生物组研究 微生物组研究
- 胃肠病学 胃肠病学
背景情况:
- 多发性硬化症 (MS) 是一种中枢神经系统自身免疫性疾病,其特征是炎症和神经退行.
- 肠道微生物组合的变化,称为失生症,越来越多地与MS的发病有关.
- 肠-大脑轴促进双向通信,这表明肠道健康影响神经条件.
研究的目的:
- 探索免疫球蛋白Y (IgY) 补充剂在治疗多发性硬化症方面的潜力.
- 研究IgY在调节肠道微生物群和与MS相关的免疫反应中的作用.
- 评估IgY在MS治疗中的初步疗效和未来研究方向.
主要方法:
- 对肠道微生物群,多发性硬化症和IgY技术的现有文献的审查.
- 对研究IgY对肠道微生物群和免疫调节的影响的研究分析.
- 对多发性硬化症患者IgY补充剂有限的临床试验数据的检查.
主要成果:
- 肠道细菌不平衡的失生症与多发性硬化症的发展和进展有关.
- 从蛋黄中提取的IgY补充剂已经证明在调节肠道微生物群和免疫反应方面具有潜力.
- 临床初步发现表明IgY可以减少多发性硬化症的症状,并积极改变免疫特征.
结论:
- 肠道微生物群代表了多发性硬化症的可改变因素,提供了治疗机会.
- IgY补充剂是一种有前途的营养药物方法,可以影响MS的肠-大脑轴.
- 需要进一步的研究来阐明IgY的机制,优化剂量,并确认MS的长期疗效和安全性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Humoral Immune Responses
72.7K
Overview
72.7K
Immunodeficiency Diseases
937
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
937


